KEY vs RPTX · P/E 13, rev $3.92B vs $61.8M cap
KeyCorp (KEY) versus Repare Therapeutics Inc (RPTX) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Repare Therapeutics Inc (RPTX) is a biotechnology company listed on US.
Latest reported KEY revenue for 2026-06-30 was $3.92B. Net income was $1.03B. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
RPTX does not have a complete income-statement cache yet.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. RPTX currently screens at market cap $61.8M.
Not investment advice. Open the KEY and RPTX stock pages for the full models.
Not investment advice.